| (210) | Number of the EPO application | 18762111 |
| (220) | Filing date of the EPO application | 2018.09.06 |
| (80) | EPO patent specification publication (B) | EPB nr. 22/2022, 2022.06.01 |
| (110) | EPO patent number | 3679034 |
| (11) | Number of the document | MD 3679034 T2 |
| (21) | Number of the application | e 2020 0707 |
| (71) | Name(s) of applicant(s), code of the country | IMMUNIC AG, DE; |
| (72) | Name(s) of inventor(s), code of the country | FELDING Jakob, DK;
KOHLHOF Hella, DE;
GRÖPPEL Manfred, DE;
MÜHLER Rolf Andreas, DE;
VITT Daniel, DE;
CHEVRIER Carine, DE;
ZAJA Mirko, DE;
TASLER Stefan, DE; |
| (73) | Name(s) of owner(s), code of the country | IMMUNIC AG, DE; |
| (54) | Title of the invention | 1-(4-(isoxazol-5-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol derivatives and related compounds as IL-7 and IFN-gamma inhibitors for treating autoimmune diseases and chronic inflammation |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 413/04 (2006.01.01); A61K 31/4155 (2006.01.01); A61P 37/00 (2006.01.01); A61P 17/06 (2006.01.01); A61P 5/14 (2006.01.01); A61P 1/04 (2006.01.01); A61P 9/10 (2006.01.01) |
| (19) | Country | DE |
| (41) | Date of publication of the application | 2020.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.10.31 |
| (30) | Priority | 17189652, 2017.09.06, EP |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2018/073993, 2018.09.06 |
| (87) | International publication | WO 2019/048541, 2019.03.14 |